Copyright © 2010 Linda A. Lieberman and George C. Tsokos. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. M. Linker-Israeli, A. C. Bakke, R. C. Kitridou, S. Gendler, S. Gillis, and D. A. Horwitz, “Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE),” Journal of Immunology, vol. 130, no. 6, pp. 2651–2655, 1983. View at Scopus
2. E. E. Solomou, Y.-T. Juang, M. F. Gourley, G. M. Kammer, and G. C. Tsokos, “Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus,” Journal of Immunology, vol. 166, no. 6, pp. 4216–4222, 2001. View at Scopus
3. B. Kovacs, D. Vassilopoulos, S. A. Vogelgesang, and G. C. Tsokos, “Defective CD3-mediated cell death in activated T cells from patients with systemic lupus erythematosus: role of decreased intracellular TNF-alpha,” Clinical Immunology and Immunopathology, vol. 81, no. 3, pp. 293–302, 1996. View at Publisher · View at Google Scholar · View at Scopus
4. L. Xu, L. Zhang, Y. Yi, H.-K. Kang, and S. K. Datta, “Human lupus T cells resist inactivation and escape death by upregulating COX-2,” Nature Medicine, vol. 10, no. 4, pp. 411–415, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
5. M. A. Williams, A. J. Tyznik, and M. J. Bevan, “Interleukin-2 signals during priming are required for secondary expansion of $\text{CD}{8}^{+}$ memory T cells,” Nature, vol. 441, no. 7095, pp. 890–893, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
6. J. Alcocer-Varela and D. Alarcon-Segovia, “Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus,” Journal of Clinical Investigation, vol. 69, no. 6, pp. 1388–1392, 1982. View at Scopus
7. P. de Faucal, A. Godard, M. A. Peyrat, J. F. Moreau, and J. P. Soulillou, “Impaired IL2 production by lymphocytes of patients with systemic lupus erythematosus,” Annales d'Immunologie, vol. 135D, no. 2, pp. 161–172, 1984. View at Scopus
8. D. R. Wigfall, R. S. Sakai, D. J. Wallace, and S. C. Jordan, “Interleukin-2 receptor expression in peripheral blood lymphocytes from systemic lupus erythematosus patients: relationship to clinical activity,” Clinical Immunology and Immunopathology, vol. 47, no. 3, pp. 354–362, 1988. View at Scopus
9. H. Ishida, S. Kumagai, H. Umehara, et al., “Impaired expression of high affinity interleukin 2 receptors on activated lymphocytes from patients with systemic lupus erythematosus,” Journal of Immunology, vol. 139, no. 4, pp. 1070–1074, 1987. View at Scopus
10. S. N. Liossis, X. Z. Ding, G. J. Dennis, and G. C. Tsokos, “Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain,” The Journal of Clinical Investigation, vol. 101, no. 7, pp. 1448–1457, 1998. View at Scopus
11. E. J. Enyedy, M. P. Nambiar, S.-N. C. Liossis, G. Dennis, G. M. Kammer, and G. C. Tsokos, “Fc$\epsilon$ receptor type I $\gamma$ chain replaces the deficient T cell receptor $\zeta$ chain in T cells of patients with systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 44, no. 5, pp. 1114–1121, 2001. View at Scopus
12. G. C. Tsokos, M. P. Nambiar, K. Tenbrock, and Y.-T. Juang, “Rewiring the T-cell: signaling defects and novel prospects for the treatment of SLE,” Trends in Immunology, vol. 24, no. 5, pp. 259–263, 2003. View at Publisher · View at Google Scholar · View at Scopus
13. Y.-T. Juang, Y. Wang, E. E. Solomou, et al., “Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV,” Journal of Clinical Investigation, vol. 115, no. 4, pp. 996–1005, 2005. View at Publisher · View at Google Scholar · View at Scopus
14. C. G. Katsiari, V. C. Kyttaris, Y.-T. Juang, and G. C. Tsokos, “Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus,” Journal of Clinical Investigation, vol. 115, no. 11, pp. 3193–3204, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
15. A. Altman, A. N. Theofilopoulos, R. Weiner, D. H. Katz, and F. J. Dixon, “Analysis of T cell function in autoimmune murine strains. Defects in production of and responsiveness to interleukin 2,” Journal of Experimental Medicine, vol. 154, no. 3, pp. 791–808, 1981. View at Scopus
16. D. Wofsy, E. D. Murphy, J. B. Roths, M. J. Dauphinée, S. B. Kipper, and N. Talal, “Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene,” Journal of Experimental Medicine, vol. 154, no. 5, pp. 1671–1680, 1981. View at Scopus
17. J.-L. Davignon, P. L. Cohen, and R. A. Eisenberg, “Rapid T cell receptor modulation accompanies lack of in vitro mitogenic responsiveness of double negative T cells to anti-CD3 monoclonal antibody in MRL/Mp-lpr/lpr mice,” Journal of Immunology, vol. 141, no. 6, pp. 1848–1854, 1988. View at Scopus
18. B. Hahn and R. R. Singh, “Animal models of systemic lupus erythematosus,” in Dubois' Lupus Erythematosus, D. J. Wallace, Ed., Lippincott Williams & Wilkin, Philadelphia, Pa, USA, 7th edition, 2007.
19. H. Schorle, T. Holtschke, T. Hunig, A. Schimpl, and I. Horak, “Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting,” Nature, vol. 352, no. 6336, pp. 621–624, 1991. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
20. B. Sadlack, H. Merz, H. Schorle, A. Schimpl, A. C. Feller, and I. Horak, “Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene,” Cell, vol. 75, no. 2, pp. 253–261, 1993. View at Publisher · View at Google Scholar · View at Scopus
21. H. Suzuki, T. M. Kundig, C. Furlonger, et al., “Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor $\beta$,” Science, vol. 268, no. 5216, pp. 1472–1476, 1995. View at Scopus
22. T. R. Malek, A. Yu, V. Vincek, P. Scibelli, and L. Kong, “CD4 regulatory T cells prevent lethal autoimmunity in IL-2R$\beta$-deficient mice: implications for the nonredundant function of IL-2,” Immunity, vol. 17, no. 2, pp. 167–178, 2002. View at Publisher · View at Google Scholar · View at Scopus
23. M. K. Kennedy, M. Glaccum, S. N. Brown, et al., “Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice,” Journal of Experimental Medicine, vol. 191, no. 5, pp. 771–780, 2000. View at Publisher · View at Google Scholar · View at Scopus
24. M. Aringer, G. H. Stummvoll, G. Steiner, et al., “Serum interleukin-15 is elevated in systemic lupus erythematosus,” Rheumatology, vol. 40, no. 8, pp. 876–881, 2001. View at Scopus
25. L. Baranda, H. de la Fuente, E. Layseca-Espinosa, et al., “IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus,” Rheumatology, vol. 44, no. 12, pp. 1507–1513, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
26. I. B. Mcinnes, J. Al-Mughales, M. Field, et al., “The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis,” Nature Medicine, vol. 2, no. 2, pp. 175–182, 1996. View at Publisher · View at Google Scholar · View at Scopus
27. C. Gabay and I. B. McInnes, “The biological and clinical importance of the ‘new generation’ cytokines in rheumatic diseases,” Arthritis Research and Therapy, vol. 11, no. 3, article 230, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
28. E.-L. Allard, M.-P. Hardy, J. Leignadier, et al., “Overexpression of IL-21 promotes massive $\text{CD}{8}^{+}$ memory T cell accumulation,” European Journal of Immunology, vol. 37, no. 11, pp. 3069–3077, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
29. K. Ozaki, R. Spolski, R. Ettinger, et al., “Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6,” Journal of Immunology, vol. 173, no. 9, pp. 5361–5371, 2004. View at Scopus
30. A. H. Sawalha, K. M. Kaufman, J. A. Kelly, et al., “Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus,” Annals of the Rheumatic Diseases, vol. 67, no. 4, pp. 458–461, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
31. J. A. Bubier, T. J. Sproule, O. Foreman, et al., “A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 5, pp. 1518–1523, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
32. R. Ettinger, S. Kuchen, and P. E. Lipsky, “The role of IL-21 in regulating B-cell function in health and disease,” Immunological Reviews, vol. 223, no. 1, pp. 60–86, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
33. H. Mitoma, T. Horiuchi, Y. Kimoto, et al., “Decreased expression of interleukin-21 receptor on peripheral B lymphocytes in systemic lupus erythematosus,” International Journal of Molecular Medicine, vol. 16, no. 4, pp. 609–615, 2005. View at Scopus
34. L. M. D'Cruz and L. Klein, “Development and function of agonist-induced $\text{CD}{25}^{+}$$\text{Foxp}{3}^{+}$ regulatory T cells in the absence of interleukin 2 signaling,” Nature Immunology, vol. 6, no. 11, pp. 1152–1159, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
35. J. Dhein, H. Walczak, C. Baumler, K.-M. Debatin, and P. H. Krammer, “Autocrine T-cell suicide mediated by APO-1/(Fas/CD95),” Nature, vol. 373, no. 6513, pp. 438–441, 1995.
36. H.-K. Sytwu, R. S. Liblau, and H. O. McDevitt, “The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice,” Immunity, vol. 5, no. 1, pp. 17–30, 1996. View at Publisher · View at Google Scholar
37. Z. Dai, A. Arakelov, M. Wagener, B. T. Konieczny, and F. G. Lakkis, “The role of the common cytokine receptor $\gamma$-chain in regulating IL-2- dependent, activation-induced $\text{CD}{8}^{+}$ T cell death,” Journal of Immunology, vol. 163, no. 6, pp. 3131–3137, 1999.
38. A. La Cava, “T-regulatory cells in systemic lupus erythematosus,” Lupus, vol. 17, no. 5, pp. 421–425, 2008. View at Publisher · View at Google Scholar · View at PubMed
39. J.-H. Lee, L.-C. Wang, Y.-T. Lin, Y.-H. Yang, D.-T. Lin, and B.-L. Chiang, “Inverse correlation between $\text{CD}{4}^{+}$ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus,” Immunology, vol. 117, no. 2, pp. 280–286, 2006. View at Publisher · View at Google Scholar · View at PubMed
40. X. Valencia, C. Yarboro, G. Illei, and P. E. Lipsky, “Deficient $\text{CD}{4}^{+}$CD25high T regulatory cell function in patients with active systemic lupus erythematosus,” Journal of Immunology, vol. 178, no. 4, pp. 2579–2588, 2007.
41. C. S. Via, G. C. Tsokos, B. Bermas, M. Clerici, and G. M. Shearer, “T cell-antigen-presenting cell interactions in human systemic lupus erythematosus: evidence for heterogeneous expression of multiple defects,” Journal of Immunology, vol. 151, no. 7, pp. 3914–3922, 1993.
42. G. C. Tsokos, “Overview of cellular immune function in systemic lupus erythematosus,” in Systemic Lupus Erythematosus, R. G. Lahita, Ed., pp. 29–92, Academic Press, 4th edition, 2004.
43. T. R. Malek, B. O. Porter, E. K. Codias, P. Scibelli, and A. Yu, “Normal lymphoid homeostasis and lack of lethal autoimmunity in mice containing mature T cells with severely impaired IL-2 receptors,” Journal of Immunology, vol. 164, no. 6, pp. 2905–2914, 2000.
44. T. R. Malek, A. Yu, P. Scibelli, M. G. Lichtenheld, and E. K. Codias, “Broad programming by IL-2 receptor signaling for extended growth to multiple cytokines and functional maturation of antigen-activated T cells,” Journal of Immunology, vol. 166, no. 3, pp. 1675–1683, 2001.
45. L. P. Cousens, J. S. Orange, and C. A. Biron, “Endogenous IL-2 contributes to T cell expansion and IFN-$\gamma$ production during lymphocytic choriomeningitis virus infection,” Journal of Immunology, vol. 155, no. 12, pp. 5690–5699, 1995.
46. J. Huang, K. W. Kerstann, M. Ahmadzadeh, et al., “Modulation by IL-2 of CD70 and CD27 expression on $\text{CD}{8}^{+}$ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy,” Journal of Immunology, vol. 176, no. 12, pp. 7726–7735, 2006.
47. A. F. Ochsenbein, S. R. Riddell, M. Brown, et al., “CD27 expression promotes long-term survival of functional effector-memory $\text{CD}{8}^{+}$ cytotoxic T lymphocytes in HIV-infected patients,” Journal of Experimental Medicine, vol. 200, no. 11, pp. 1407–1417, 2004. View at Publisher · View at Google Scholar · View at PubMed
48. V. Peperzak, Y. Xiao, E. A. M. Veraar, and J. Borst, “CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production,” Journal of Clinical Investigation, vol. 120, no. 1, pp. 168–178, 2010. View at Publisher · View at Google Scholar · View at PubMed
49. P. Blanco, V. Pitard, J.-F. Viallard, J.-L. Taupin, J.-L. Pellegrin, and J.-F. Moreau, “Increase in activated $\text{CD}{8}^{+}$ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 52, no. 1, pp. 201–211, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
50. J. A. James, K. M. Kaufman, A. D. Farris, E. Taylor-Albert, T. J. A. Lehman, and J. B. Harley, “An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus,” Journal of Clinical Investigation, vol. 100, no. 12, pp. 3019–3026, 1997. View at Scopus
51. B. D. Poole, A. K. Templeton, J. M. Guthridge, E. J. Brown, J. B. Harley, and J. A. James, “Aberrant Epstein-Barr viral infection in systemic lupus erythematosus,” Autoimmunity Reviews, vol. 8, no. 4, pp. 337–342, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus